Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 1
1976 1
1980 1
1983 1
1984 1
1987 2
1989 1
1990 1
1991 1
1992 2
1993 4
1994 8
1995 7
1996 5
1997 10
1998 5
1999 4
2000 10
2001 5
2002 9
2003 8
2004 9
2005 6
2006 21
2007 7
2008 20
2009 16
2010 19
2011 21
2012 36
2013 30
2014 38
2015 45
2016 49
2017 33
2018 24
2019 36
2020 36
2021 40
2022 40
2023 37
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Moyamoya disease 5"
Page 1
RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome.
Rocha EA, Topcuoglu MA, Silva GS, Singhal AB. Rocha EA, et al. Neurology. 2019 Feb 12;92(7):e639-e647. doi: 10.1212/WNL.0000000000006917. Epub 2019 Jan 11. Neurology. 2019. PMID: 30635475
Beta coefficients from the multivariate regression model yielding the best c-statistic (0.989) were used to develop the RCVS(2) score (range -2 to +10; recurrent/single thunderclap headache; carotid artery involvement; vasoconstrictive trigger; sex; subarachnoid hemorrhage). Scor …
Beta coefficients from the multivariate regression model yielding the best c-statistic (0.989) were used to develop the RCVS(2) score (range …
Stroke in Asia.
Tan KS, Pandian JD, Liu L, Toyoda K, Leung TWH, Uchiyama S, Kuroda S, Suwanwela NC, Aaron S, Chang HM, Venketasubramanian N. Tan KS, et al. Cerebrovasc Dis Extra. 2024;14(1):58-75. doi: 10.1159/000538928. Epub 2024 Apr 26. Cerebrovasc Dis Extra. 2024. PMID: 38657577 Free article. Review.
Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be anticipated annually in the backdrop of a diverse group of well-developed and less developed countries with large disparities in stroke care resou …
Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be antici …
Limb-shaking TIA in Moyamoya angiopathy.
Das S, Ghosh R, Dubey S, Pandit A, Ray BK, Kraemer M. Das S, et al. Clin Neurol Neurosurg. 2021 Aug;207:106783. doi: 10.1016/j.clineuro.2021.106783. Epub 2021 Jun 27. Clin Neurol Neurosurg. 2021. PMID: 34225004
Seven previously reported cases of LS-TIA in MMA were retrieved by literature search in PubMed using keywords "Moyamoya" AND "Limb shaking TIA", "Moyamoya" AND "Limb shaking". Subsequently all data were analyzed and compared using descriptive statistics. ...The comm …
Seven previously reported cases of LS-TIA in MMA were retrieved by literature search in PubMed using keywords "Moyamoya" AND "Limb sh …
Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis.
Singh R, Bauman MMJ, Seas A, Harrison DJ, Pennington Z, Brown NJ, Gendreau J, Rahmani R, Ellens N, Catapano J, Lawton MT. Singh R, et al. Neurosurg Rev. 2023 Sep 2;46(1):220. doi: 10.1007/s10143-023-02123-z. Neurosurg Rev. 2023. PMID: 37658996
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or autoimmune (AI) processes have been suggested to instigate or exacerbate the condition, but the data remains mixed. ...Of the 148 patients wh …
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or a …
Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome.
Das S, Ray BK, Pandit A, Ghosh R, Chakraborty AP, Dubey S. Das S, et al. Eur J Paediatr Neurol. 2022 Nov;41:63-70. doi: 10.1016/j.ejpn.2022.10.002. Epub 2022 Oct 17. Eur J Paediatr Neurol. 2022. PMID: 36368232
OBJECTIVES: Moyamoya Angiopathy (MMA) is a chronic, progressive intracranial vasculopathy. Unlike Sickle-cell-disease, thalassemia-syndrome has rarely been described in association with MMA. ...
OBJECTIVES: Moyamoya Angiopathy (MMA) is a chronic, progressive intracranial vasculopathy. Unlike Sickle-cell-disease, thalass …
Radiation-induced moyamoya syndrome.
Desai SS, Paulino AC, Mai WY, Teh BS. Desai SS, et al. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1222-7. doi: 10.1016/j.ijrobp.2006.01.038. Epub 2006 Apr 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16626890 Review.
Radiation-induced moyamoya syndrome occurred in 27.7% of patients by 2 years, 53.2% of patients by 4 years, 74.5% of patients by 6 years, and 95.7% of patients by 12 years after RT. CONCLUSIONS: Patients who received RT to the parasellar region at a young age (< …
Radiation-induced moyamoya syndrome occurred in 27.7% of patients by 2 years, 53.2% of patients by 4 years, 74.5% of patients …
Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR, Antoniazzi AM, Miller R, Klyde D, Javed K, Fluss R, Holland R, De la Garza Ramos R, Haranhalli N, Altschul DJ. Unda SR, et al. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105965. doi: 10.1016/j.jstrokecerebrovasdis.2021.105965. Epub 2021 Jul 8. J Stroke Cerebrovasc Dis. 2021. PMID: 34247053
OBJECTIVES: Ischemic stroke and hemorrhagic stroke are the most common sequelae of the Moyamoya variants [Moyamoya disease (MMD) and syndrome (MMS)]. We sought to determine the rates of stroke subtypes and the predictive factors of arterial ischemic stroke (A …
OBJECTIVES: Ischemic stroke and hemorrhagic stroke are the most common sequelae of the Moyamoya variants [Moyamoya disease …
An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.
Kim JE, Jeon JS. Kim JE, et al. Neurol Res. 2014 May;36(5):407-16. doi: 10.1179/1743132814Y.0000000351. Epub 2014 Mar 18. Neurol Res. 2014. PMID: 24641716 Review.
Moyamoya disease (MMD) is characterized by a chronic progressive steno-occlusive disease at the distal portion of the internal carotid artery (ICA) with abnormal Moyamoya vessel (MMV) development without associated diseases. ...Although treatment of pe …
Moyamoya disease (MMD) is characterized by a chronic progressive steno-occlusive disease at the distal portion of the i …
Moyamoya Disease: A Review of Clinical Research.
Hishikawa T, Sugiu K, Date I. Hishikawa T, et al. Acta Med Okayama. 2016 Aug;70(4):229-36. doi: 10.18926/AMO/54497. Acta Med Okayama. 2016. PMID: 27549666 Free article. Review.
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. ...
About 5 decades have passed since the concept of moyamoya disease (MMD) was established in Japan. ...
Moyamoya disease: current concepts and future perspectives.
Kuroda S, Houkin K. Kuroda S, et al. Lancet Neurol. 2008 Nov;7(11):1056-66. doi: 10.1016/S1474-4422(08)70240-0. Lancet Neurol. 2008. PMID: 18940695 Review.
The incidence of moyamoya disease is high in east Asia, and familial forms account for about 15% of patients with this disease. Moyamoya disease has several unique clinical features, which include two peaks of age distribution at 5 years …
The incidence of moyamoya disease is high in east Asia, and familial forms account for about 15% of patients with this dise …
568 results